Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 231.06 USD 0.68%
Market Cap: 19.3B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note
Section:
 

Relative Value

The Relative Value of one LH stock under the Base Case scenario is 326.43 USD. Compared to the current market price of 231.06 USD, Laboratory Corporation of America Holdings is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LH Relative Value
Base Case
326.43 USD
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
34
vs Industry
57
Median 3Y
1.5
Median 5Y
1.5
Industry
2.3
Forward
1.4
More Details
44.4
P/E
P/E
Price to Earnings
44.4
vs History
6
vs Industry
12
Median 3Y
17.1
Median 5Y
17.2
Industry
23.1
Forward
15.5
More Details
13.9
P/OCF
P/OCF
Price to OCF
13.9
vs History
9
vs Industry
25
Median 3Y
10
Median 5Y
9.1
Industry
14.2
More Details
11.4
P/FCFE
P/FCFE
Price to FCFE
11.4
vs History
76
vs Industry
9
Median 3Y
13.6
Median 5Y
13.4
Industry
20.1
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
9
vs Industry
38
Median 3Y
2.1
Median 5Y
2.1
Industry
2.2
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
33
vs Industry
53
Median 3Y
1.8
Median 5Y
1.8
Industry
2.4
Forward
1.7
More Details
6.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.6
vs History
7
vs Industry
36
Median 3Y
6.2
Median 5Y
5.9
Industry
5
More Details
13.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.2
vs History
1
vs Industry
28
Median 3Y
10.3
Median 5Y
9.4
Industry
12.7
Forward
10.3
More Details
20.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.5
vs History
1
vs Industry
24
Median 3Y
14.8
Median 5Y
13
Industry
17.1
Forward
12.5
More Details
16.7
EV/OCF
EV/OCF
Enterprise Value to OCF
16.7
vs History
6
vs Industry
23
Median 3Y
12.7
Median 5Y
11.9
Industry
14
More Details
27.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.6
vs History
6
vs Industry
15
Median 3Y
17.3
Median 5Y
15.8
Industry
18
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
22
vs Industry
50
Median 3Y
1.3
Median 5Y
1.3
Industry
1.9
More Details

Multiples Across Competitors

LH Competitors Multiples
Laboratory Corporation of America Holdings Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
AU
Sonic Healthcare Ltd
ASX:SHL
13.1B AUD 1.5 25.6 19.2 19.2
P/E Multiple
Earnings Growth PEG
US
Laboratory Corporation of America Holdings
NYSE:LH
Average P/E: 26.8
44.4
54%
0.8
US
Cigna Corp
NYSE:CI
25.9
25%
1
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
48.1
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.5
12%
1.7
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
253%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
31%
0.8
US
DaVita Inc
NYSE:DVA
15.5
17%
0.9
AU
Sonic Healthcare Ltd
ASX:SHL
25.6
11%
2.3

See Also

Summary
LH intrinsic value, competitors valuation, and company profile.
DCF Valuation
LH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LH stock valuation using valuation multiples.
Wall Street Estimates
LH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.